Octave Bioscience’s MSDA Test Proven to Provide Clinically Actionable Insights That Drive Meaningful Clinical Decisions in MS Care

The Octave MSDA Test is being used by leading MS Centers of Excellence, academic institutions, and independent neurology practices across the United States, providing clinicians with critical biomarker-driven insights to support treatment decisions.

Continue ReadingOctave Bioscience’s MSDA Test Proven to Provide Clinically Actionable Insights That Drive Meaningful Clinical Decisions in MS Care